Press Release: QURE Healthcare Accelerates Growth Trajectory with Scott Pope, PharmD, joining as Vice President

QURE Healthcare is pleased to announce Scott Pope, PharmD has joined as company Vice President of Strategy and Solutions. Dr. Pope brings a deep background in healthcare quality performance improvement and a proven track record of rapidly growing market penetration for numerous healthcare innovations.  In addition to his clinical experience as an infectious diseases pharmacist, for more than a decade Scott has helped health systems, life science companies, and outcomes research efforts provide safer, better and more cost-effective healthcare. 

As QURE Healthcare continues to expand, Dr. Pope will lead the go-to-market strategies and sales initiatives for QURE’s unique Clinical Performance and Value (CPV®) vignettes.

“We are thrilled to welcome Dr. Pope to the QURE team.  Scott shares our mission to engage physicians and transform clinical care. His unique skills as a clinician and sales director are a differentiator for the future of our business. I am delighted that Dr. Pope will be able to impact the care of more patients with our CPV® technology by joining our organization,” said Dr. John Peabody, QURE’s President and Founder. “Scott’s extensive experiences in both clinical practice and the business of delivering better healthcare are a formidable pair and the perfect combination to help us reach our growth goals.”
“My career has been dedicated to advancing the adoption of processes, technologies, products, and collaborations that produce higher quality, lower cost healthcare.  In that spirit, there is an abundance of peer-reviewed data clearly demonstrating the ability of the QURE approach to reduce costly care variation and doing so in a way that physicians and other providers embrace,” said Dr. Pope. “QURE’s solutions are a tried, true, and flexible means for helping health systems reach many of their current cost and quality objectives. I am elated to join the QURE family and responsible for expanding the adoption of a solution that is precisely what healthcare is seeking.” 

Dr. Peabody added, “QURE has strategic partnerships with some of the most thoughtful Fortune 500 companies.  As we grow in this area QURE needed senior leadership in sales, business development, and marketing to guide these vital relationships—relationships we expect to use as we transform clinical care in every hospital and every sector we engage.”

About Scott D. Pope, PharmD

Dr. Pope sparked his career with nearly a decade at Premier, Inc. (NASDAQ: PINC) in a wide range of roles with increasing responsibility in sales, marketing, new business development, monetizing intellectual property, and new product commercialization.  He most recently comes from Northwestern Capital Partners, LLC where he headed up clinical due diligence processes, designed go to market strategies for portfolio companies, and recruited new portfolio prospects. Pope holds a PharmD and minor in business administration from Ohio Northern University.  He completed a pharmacy practice residency at Moses Cone Memorial Hospital and a specialty residency in infectious disease, internal medicine, and academics through Campbell University at Duke University Medical Center.  (